Earnings Watching: Earnings Per Share projected to Decrease for GW Pharmaceuticals PLC- ADR (GWPH) according to bullish analystsDecember 4, 2016 - By mmahotstuffWall Street await GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) to release earnings on December, 5. After posting $-0.73 EPS for the previous quarter, GW Pharmaceuticals PLC- ADR’s analysts now forecast 102.74% negative EPS growth. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) has risen 36.10% since May 2, 2016 and is uptrending. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Ratings CoverageOut of 8 analysts covering GW Pharmaceuticals (NASDAQ:GWPH), 6 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. More interesting news about GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) were released by: Investorplace.com and their article: “GW Pharmaceuticals PLC- ADR Is a First-Rate Marijuana Stock (GWPH)” published on September 26, 2016 as well as Investorplace.com‘s news article titled: “GW Pharmaceuticals PLC- ADR (GWPH) Boards the Buyout Rumor Mill” with publication date: September 07, 2016.

Source: Wall Street Journal December 04, 2016 11:21 UTC